DC Chemicals · Product datasheet

Bohemine — Datasheet

CAT. NO. DC8073

Product page and current package options

ParameterValue
Chemical Name1-Propanol,3-[[9-(1-methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-
CAS No.189232-42-6
Synonyms1-Propanol,3-[[9-(1-methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-;3-[[6-(benzylamino)-9-propan-2-ylpurin-2-yl]amino]propan-1-ol;BOHEMINE;2-(3-hydroxypropylamino)-6-benzylamino-9-isopropylpurine;2-[(3-hydroxypropyl)amino]-6-benzylamino-9-isopropylpurine;AC1L1DN2;CHEMBL83980;CTK8A4395;DNC003611;HMS3229C10;HSCI1_000064;purine deriv. 1;SureCN1443403;Bohemin;3-{[6-(Benzylamino)-9-Isopropyl-9H-Purin-2-Yl]Amino}-1-Propanol;3-((6-(benzylaMino)-9-isopropyl-9H-purin-2-yl)aMino)propan-1-ol
FormulaC18H24N6O
M.Wt340.42276
SMILESCC(C)N1C=NC2=C(NCC3=CC=CC=C3)NC(=NCCCO)N=C21
Purity>98%
Storage2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Biological Activity

Bohemine is a purine analogue and is a synthetic and selective CDK inhibitor with IC50s of 4.6 μM, 83 μM, and 2.7 μM for Cdk2/cyclin E, Cdk2/cyclin A, and Cdk9/cyclin T1, respectively. Bohemine also inhibits ERK2 with an IC50 of 52 μM and has less inhibitory effect on CDK1, CDK4 and CDK6. Bohemine has a broad spectrum anti-cancer activities[1][2].

In Vitro

Bohemine (0-30 µM; 72 hours; ME-750 cells) treatment inhibits cell growth. Addition of Bohemine at concentrations in the range of 1-10 µM results in a short-term arrest of growth and of monoclonal antibody production. The short-term suppression of cell functions is followed by a significant temporary increase of specific growth rate and of specific production rate[1]. Hybridoma cells are retarded both at the G1/S boundary and at the G2/M boundary, depending on Bohemine (0-30 µM) concentration[1]. T-lymphoblastic cell line CEM is treated by Bohemine, five proteins are found to be downregulated, namely α-enolase, triosephosphate isomerase, initiation factor 5A, and α- and β-subunits of Rho GDP-dissociation inhibitor 1. These proteins play significant roles in glycolysis, proteosynthesis, and in cytoskeleton rearrangement[1]. Bohemine inhibits growth of human tumor cell lines with an IC50 of 27 µM[2]. Cell Viability Assay[1] Cell Line: Mouse hybridoma ME-750 cells Concentration: 0 µM, 1 µM, 3 µM, 10 µM and 30 µM Incubation Time: 72 hours Result: At 10 µM and 30 µM concentrations, the viable cell count was significantly lower with respect to control, i.e., 77% and 48%, respectively.

In Vivo

Bohemine (50 mg/kg; intravenous injection; BALB/c mice) treatment shows Cmax is 72,308 nM, observed clearance is 0.23 L/h and T1/2 is 1.39 h[2]. Animal Model: BALB/c mice bearing the colon 26 murine tumor[2] Dosage: 50 mg/kg Administration: Intravenous injection (Pharmacokinetic Analysis) Result: Cmax is 72,308 nM, observed clearance is 0.23 L/h and T1/2 is 1.39 h.

References & source

DC Chemicals original product information

Published experimental findings depend on the model and assay conditions. They do not guarantee equivalent performance in every application. For laboratory research use only.

Cart

Request quotation